Multiple targeted antitumor immune cell therapy adopts five core cells, DC, CTL, NK, γδT, CD3AK, which set up a multi-dimension therapy to fight against cancers so as to largely reduce the rate of cancer recurrence. Multiple targeted antitumor immune cell therapy is also called “super cells”.【Read More】
- ◎Strengthen the Immunity to Fight against Cancers Independently
- ◎Clinical Safety and Few Side-effects
- ◎Relieve the Pain of Cancer and Prolong Patients’ Lifetime
- ◎Combined Therapy Makes up the Deficiencies of Traditional Therapy
- ◎Peculiar and Precise, Strongly Targeted in Cancer Killing
- ◎Strengthen Immunity to Fight against Cancers Independently
Biological immunotherapy is a kind of tumor biotherapies. It kills and wounds tumors directly or induces the anti-tumor immunoreaction of the body via transfusing immune cells with antitumor activity into patients.【Read More】
- ◎Precise: Increase the peculiarity of killing tumor
- ◎Extensive: Apply in many kinds of tumor treatment
- ◎Comprehensive: Improve the immunity function of the body
- ◎Durable: Activate the immune memory function
- ◎Radical: Remove the residual tumor cells
- ◎Safe: No toxic side effects
ACTL cell targeted therapy uses the way to collect patients’ own cells and takes recombinant adeno-associated virus (rAAV) that carries anti-cancer gene as the carrier to transfuse in vitro prepared CTL cells into the patient through intravenous ways and ultimately kill tumor with these CTL cells.【Read More】
- ◎Safety: AAV (Adeno-associated virus) has no toxic side effects to the body
- ◎Reversal of Drug Resistance: Improve radiotherapy and chemotherapy efficacy of patients
- ◎Targeting Ability: CTL cells directly kill tumor
- ◎Short Treatment Course: Single treatment lasts 12-14 days
- ◎High Efficiency: Obtain a large amount of CTL cells through rAAV genes
- ◎Smaller Trauma, Less Pain and Prevent Cancer Recurrence